Vifor Pharma's proposals to end probe provisionally accepted, UK's CMA says
MLex Summary: Vifor Pharma has made commitments to end a probe into whether it breached competition law in the market for iron treatments by disparaging a rival product, the UK antitrust regulator...To view the full article, register now.
Already a subscriber? Click here to view full article